Notably, Bclxl overexpression did not prevent somal shrinkage or PERG amplitude decline after axonal injury, suggesting BCLXL loss is not the sole driver of RGC somal degeneration in the context of glaucoma. The gene discussed is BCL2L1; the disease is glaucoma.